Leprosy
Leprosy
Leprosy
management
Two types of reactions
Mild Severe
Red raised skin plaques Ulcerating skin lesions
Red, tender Painful or tender nerves
subcutaneous nodules Recent ( 6 mts) NFI
Enlarged, non-tender Reaction lesions in the
nerves face
Severe oedema
Involvement of other
organs.
Type 1 Reaction
(1)
Type 1 Reaction
(2)
Type 1 Reaction (3)
Type 1 Reaction (4)
Type 1 Reaction (5)
Type 1 Reaction (6)
Type 1 Reaction (7)
ENL Reaction (1)
ENL Reaction (2)
ENL Reaction (3)
ENL Reaction (4)
ENL Reaction: Iritis
Making the diagnosis
History
Physical examination
Skin signs
Nerve palpation
NFA – sensory or motor impairment?
Systemic signs (edema, fever, other organs)
Criteria for sensory and motor impairment
Criteria for reaction and severe neuritis.
Management of nerve damage
Medical
Surgical
Supportive.
Medical management
Adults
PB: starting dose 40 mg daily, duration 12 weeks
MB: starting dose 40 mg daily, duration 24 weeks
Children
30 mg daily for one week, then alternate days,
tapering as above (12 weeks).
Patients over 15 years
PB: MB:
40 mg od for 2 weeks 40 mg od for 4 weeks
30 mg od for 2 weeks 30 mg od for 4 weeks
20 mg od for 2 weeks 20 mg od for 4 weeks
15 mg od for 2 weeks 15 mg od for 4 weeks
10 mg od for 2 weeks 10 mg od for 4 weeks
5 mg od for 2 weeks 5 mg od for 4 weeks
Total: 16 weeks Total: 24 weeks
Children up to 15
30 mg od for 1 week
30 mg alternate days for 1 week
25 mg alternate days for 2 weeks
20 mg alternate days for 2 weeks
15 mg alternate days for 2 weeks
10 mg alternate days for 2 weeks
5 mg alternate days for 2 weeks
Total: 12 weeks
Contraindications
Acute or chronic untreated bacterial or parasitic
infection, e.g.
TB
Corneal ulcer
Worm infestation
Scabies
Fungal infection
Current peptic ulcer or recent history of
haematemesis or melaena
Past history of psychosis or endogenous depression.
Relative contraindications
Psychosis 0 0
Glaucoma 0 0
TB 0 0
Acne 2% 0.7%
Fungal infections 1% 0